Search This Blog

Tuesday, September 1, 2026

EU states ready to join new Lebanon mission against Iran-backed Hezbollah

 

More than 10 European Union member states are willing to contribute personnel and resources to a proposed military and civilian mission to advise and train Lebanese forces, EU foreign policy chief Kaja Kallas said on Tuesday.

The mission is intended to strengthen Lebanon’s Internal Security Forces, helping free up the Lebanese army to focus on disarming the Iran-backed militant group Hezbollah.

Discussions over the possible EU mission come as the mandate of the United Nations Interim Force in Lebanon is due to expire at the end of 2026.

https://www.iranintl.com/en/202609010399

Remibrutinib Phase 3 MS success drives Novartis premarket surge

 

Remibrutinib Phase 3 MS success drives Novartis 4.64% premarket surge

  • Novartis announced positive REMODEL-1/2 Phase 3 results early today for oral BTK inhibitor remibrutinib in relapsing multiple sclerosis (RMS).
  • Drug met primary endpoint with significant reduction in annualized relapse rate versus Sanofi's Aubagio (teriflunomide).
  • Remibrutinib showed superiority on key secondaries including MRI lesion reduction and slowing disability progression.
  • Favorable safety profile reported with no new or increased liver safety signals observed.
  • Novartis plans to file for global regulatory approvals based on the strong data readout.
  • News matches timing of premarket move; viewed as key pipeline asset with substantial peak sales potential.

UnitedHealthcare to drop prior authorization requirements for 1,700 services

 UnitedHealthcare has released the specific procedure codes it will exempt from prior authorization as part of the insurer’s previous pledge to reduce requirements by 30% before the end of 2026.

The code lists cover 1,700 procedure codes for a range of services across commercial, Medicare Advantage, individual exchange, and Medicaid plans. Effective Oct. 1, providers will no longer need to seek the insurer’s approval for many outpatient procedures, including lesion excisions, fracture treatments, joint injections, arthroscopies, colonoscopies, endoscopies, biopsies, hernia repairs and soft tissue tumor removals. Genetic and molecular testing codes also make up a large  portion of the lists.

UnitedHealthcare CEO Tim Noel said in May that prior authorization “should only be used when it truly protects patients and improves care.” At the time, the insurer said it requires prior approval for just 2% of its medical services, with roughly 92% of submitted requests approved in less than 24 hours on average. The 30% reduction builds on an earlier 20% cut to commercial prior authorization requirements in 2023.

In June 2025, major insurers pledged to simplify and reduce prior auth requirements affecting plans covering 257 million Americans. As part of that, AHIP and the BCBS Association reported an 11% industrywide reduction in April. An AMA survey of 1,000 physicians published in May found that 95% reported prior auth can cause care delays, and physicians and their staff still spend an average of 13 hours per week on the process. 

In August, a KFF analysis of first-ever publicly reported prior auth data found that insurers denied at least 1 in 8 standard requests across Medicare Advantage, Medicaid managed care and ACA marketplace plans in 2025, with denial rates ranging from 12% in MA to 18% in the marketplace. When denials were appealed, two-thirds were overturned in MA and nearly half in Medicaid, though KFF noted that appeals remain rare overall.

https://www.beckershospitalreview.com/finance/unitedhealthcare-to-drop-prior-authorization-requirements-for-1700-services/

Pentagon Launches Grok And ChatGPT For Military Use

 by Timothy Frudd via The Epoch Times,

The Department of War announced the launch of two new artificial intelligence (AI) platforms for military use on Aug. 31, expanding the department's platform of AI assistants for military personnel.

Starshield AI's Grok for Government and OpenAI's ChatGPT Mil were both added to the War Department's GenAI.mil generative AI platform on Monday. The Aug. 31 launch came months after the Pentagon announced a partnership with OpenAI to deploy AI models on the Pentagon's classified networks and a partnership with Elon Musk's xAI service to assist personnel with controlled unclassified information.

Announcing the launch of Starshield AI's Grok for Government, the War Department said the AI tool would enable the military to execute missions faster and with more precision in multiple operational contexts. Examples of such contexts include supply chain management for logisticians and market research analysis for acquisition professionals.

The Pentagon said Starshield AI's Grok for Government would provide military personnel with "immediate productivity gains, stronger knowledge continuity, and more secure and efficient collaboration." Capabilities department personnel will have access to include adaptive reasoning modes, customizable workspaces, deep-thinking inference, persistent projects, and reusable "playbooks."

Starshield AI's Grok for Government was accredited for controlled unclassified information at impact level five, a designation given to unclassified information that still requires security safeguards. It was also engineered for "secure, consistent enterprise use," according to the War Department.

With the addition of Starshield AI's Grok for Government to the department's GenAI.mil platform, the Pentagon said military members would have access to another "top-tier generative AI tool." The Pentagon also said the addition of another AI tool would promote a "vibrant" AI ecosystem for the United States and would eliminate its dependence on a single AI provider.

The War Department also announced Monday that it had launched OpenAI's ChatGPT Mil as part of its GenAI.mil platform. Like Starshield AI's Grok for Government, OpenAI's ChatGPT was accredited for controlled unclassified information at impact level five.

"ChatGPT Mil brings a familiar commercial experience into the Department's secure environment, tailored to warfighter needs," the Pentagon said. "The core experience centers on chat, files, projects, and custom GPTs, with additional features sequenced over time."

The department said ChatGPT Mil will support document-heavy unclassified work, including planning, logistics, administration, and policy. Built to support more than 3 million personnel, the AI platform will increase the speed of routine tasks and allow personnel to concentrate on "more critical projects across the Joint Force," the Pentagon said.

"Integrating ChatGPT Mil into GenAI.mil alongside existing frontier AI capabilities establishes a robust, multi-model ecosystem for the warfighter," it added.

The Epoch Times reached out to Starshield AI and OpenAI for comment but did not receive a response before publication time.

The War Department confirmed Monday that more than 1.7 million of its more than 3 million personnel have been onboarded for the department's generative AI platform since GenAI.mil was launched nine months ago.

The launch of the two AI tools for use by War Department personnel comes after the Defense Counterintelligence and Security Agency warned in June that unauthorized "shadow AI" tools could cause data leaks and lead to other security risks.

"Shadow AI encompasses two distinct threat vectors: the intentional use of external commercial or private [large language models], and the activation of embedded AI features within existing government and sensitive networks that have not yet been fully evaluated for security risks," the agency wrote in an assessment.

"When bypassing traditional security controls, both vectors create a massive, unmonitored attack surface where new risks outpace current technical safeguards and governance."

https://www.zerohedge.com/ai/pentagon-launches-grok-and-chatgpt-military-use

NY Prosecutor Says He Was Told To 'Find Crimes' To Target Trump Allies

 A veteran prosecutor in New York Attorney General Letitia James' office says he was ordered to find crimes to pin on people connected to President Donald Trump, and the fallout left him on paid leave within days.

Daniel Wiesenfeld, a former Brooklyn prosecutor who moved into James' Investor Protection Bureau, sent an email to roughly 2,000 colleagues on Friday laying out what he says happened inside the office. The email disappeared from inboxes not long after it went out, but the Times-Union obtained a copy before it was deleted.

Wiesenfeld wrote that Bureau Chief Shamiso Maswoswe directed him to build cases against "Trump himself, Truth Social, Hewlett Packard (DOJ approved merger)... without having a credible reason for targeting this organizations and individuals [sic]."

The Hewlett Packard matter goes back to a $14 billion merger between Hewlett Packard Enterprise and Juniper Networks that the federal government approved. Wiesenfeld says his bureau chief wanted him to dig into a transaction that Washington had cleared. In his account, the office picked the target based on who stood to benefit rather than the merits of any case.

Wiesenfeld drew the comparison James' office would rather nobody draw. He wrote in the email, "If you believe Trump is using the [Department of Justice] attorneys to prosecute his enemies and further his political interests, you should find it equally troubling that Tish [James] is doing exactly the same thing."

He asked his colleagues to reconsider their role, writing, "I ask you that you not serve as Tish's personal attorneys by targeting her political enemies. Instead, I hope you choose to prosecute crimes and find the individuals accountable, rather than targeting individuals and then finding crimes."

Wiesenfeld pointed his colleagues toward work he considers worth the office's time, urging them to focus on "rampant nonprofit homeless shelter fraud and antisemitic crimes in and around synagogues" instead of chasing James' political enemies. He accused her of burning "significant public taxpayer dollars to target convenient public enemies."

The office placed Wiesenfeld on paid administrative leave once the email surfaced. A spokesperson for James dismissed the episode as "a personnel matter" in a statement to the Times-Union.

James' office issued a broader denial too, calling itself "committed to upholding New York's laws and protecting the rights and freedoms of all New Yorkers, regardless of political beliefs," and adding, "We strongly reject any assertion to the contrary."

However, this denial conflicts with James' own actions. In December 2018, a month after she was elected attorney general, she promised to 'prosecute the president for crimes committed in New York State.' After she took office, she certainly carried out that promise. In 2024, her office obtained a $364 million civil fraud judgment against Trump, his sons, and his company, on the grounds that he had inflated the values of his properties and misrepresented his wealth to obtain loans from Deutsche Bank. During the trial, David Williams, Deutsche Bank's own managing director, testified in Trump's defense, undermining James' assertion that Trump had defrauded the bank. The appeals court confirmed the original verdict but canceled the huge financial penalty.

For Republicans in the state, Wiesenfeld's email was confirmation of what they have argued for years.

"Letitia James weaponized the attorney general's office into a political hit squad and then tried to cover up her tracks. She is utterly unfit to serve." New York State Republican Committee Chairman Ed Cox told the New York Post. "New Yorkers deserve an attorney general who prosecutes criminals, preserves public records and enforces the law without fear or favor."

Nicole Kiprilov, spokesperson for Republican attorney general candidate Saritha Komatireddy, said, "When Saritha is attorney general, she will instruct her attorneys to lock up repeat offenders, build residential treatment for the homeless, and root out fraud - not target people because of their politics." She added, "It's good to see that even the rank-and-file in the AG's office agree that this is the right way forward. Let's work together - across partisan lines - and create a safer, more affordable New York."

Komatireddy built her resume for exactly this argument, spending years in the U.S. Attorney's Office for the Eastern District of New York in Brooklyn as chief of International Narcotics and Money Laundering, deputy chief of Appeals, and deputy chief of General Crimes. She also clerked for then-Circuit Judge Brett Kavanaugh on the U.S. Court of Appeals.

But what's really telling is that even James' fellow Democrats aren't rushing to her defense.

Melissa DeRosa, a former aide to former Gov. Andrew Cuomo, wrote on X that James "has been abusing her office for political gain for years." DeRosa followed with a line that cuts both ways, writing, "Don't criticize Trump's use of DOJ if you're not going to call out hers -/ it's wrong when either side does it."

https://www.zerohedge.com/political/ny-prosecutor-says-he-was-told-find-crimes-target-trump-allies

Alumis Phase 2b lupus trial misses primary, secondary endpoints; subgroup data support Phase 3 plans

 

Alumis Phase 2b LUMUS SLE trial misses primary and secondary endpoints as IFNGS-high subgroup data support Phase 3 plans

  • LUMUS Phase 2b study tested envudeucitinib in patients with systemic lupus erythematosus across an overall population.
  • Company plans Phase 3 development based on strong IFNGS-high subgroup response in systemic lupus erythematosus.

Medtronic beats, ups FY27 organic growth and EPS guidance

 

Medtronic beats Q1 FY27 estimates with EPS $1.45, revenue $9.8B and raises FY27 organic growth and EPS guidance

  • Q1 revenue $9.8B, organic +13.7%; underlying growth ~7% after adjusting for extra selling week benefit.
  • Adjusted EPS $1.45, $0.06 above guidance midpoint and Street; gross and operating margins up slightly YoY.
  • FY27 organic revenue growth guidance raised 50 bps to 7.25–7.75%, with EPS outlook increased to $5.94–6.00.
  • FY27 operating profit guided to grow about 10%, with approximately 50 bps margin expansion despite growth reinvestment.
  • Cardiac Ablation Solutions grew 88%, topping $2B trailing revenue and expected to grow 2.5–3x the overall market.
  • Strong quarter with robust procedural strength across CRM, Cranial & Spinal, Surgical, Pelvic Health and Diabetes franchises.
  • Free cash flow strong, with 70% conversion in Q1 and a clear articulated path toward 80%.
  • MiniMed diabetes separation targeted by fiscal year-end, expected to lift gross and operating margins by 50–100 bps.
  • Agreed to approximately $700M Cornerstone Robotics deal for Sentire surgical robot rights in select markets outside the U.S.
  • Partnership with Cornerstone and Pi-Cardia aims to expand Medtronic's soft-tissue robotics and structural heart treatment ecosystems.
  • Medtronic secures exclusive global distribution rights from 2027 for Pi-Cardia's FDA-cleared ShortCut TAVR leaflet-modification device.
  • Deal includes option to acquire Pi-Cardia for up to about $210M plus earn-outs and up to $80M ShortCut agreement investment.
  • Investor focus and concern center on CAS growth sustainability, robotics strategy execution and MiniMed diabetes separation timing and economics.